These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1867297)

  • 1. Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis.
    Nussenblatt RB; Palestine AG; Chan CC; Stevens G; Mellow SD; Green SB
    Am J Ophthalmol; 1991 Aug; 112(2):138-46. PubMed ID: 1867297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin.
    Nussenblatt RB; de Smet MD; Rubin B; Freidlin V; Whitcup SM; Davis J; Herman D; Bloom JN; Sran PK; Whitcher S
    Am J Ophthalmol; 1993 May; 115(5):583-91. PubMed ID: 8488909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
    Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
    Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine therapy for uveitis: long-term followup.
    Nussenblatt RB; Palestine AG; Chan CC
    J Ocul Pharmacol; 1985; 1(4):369-82. PubMed ID: 3880086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Adalimumab in Active Noninfectious Uveitis: A Pilot Study.
    Hamam RN; Barikian AW; Antonios RS; Abdulaal MR; Alameddine RM; El Mollayess G; Mansour AM
    Ocul Immunol Inflamm; 2016 Jun; 24(3):319-26. PubMed ID: 25549063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.
    Sheppard JD; Toyos MM; Kempen JH; Kaur P; Foster CS
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2993-3002. PubMed ID: 24677110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of cyclosporine treatment for noninfectious uveitis.
    Lee SH; Chung H; Yu HG
    Korean J Ophthalmol; 2012 Feb; 26(1):21-5. PubMed ID: 22323881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis.
    Palestine AG; Austin HA; Nussenblatt RB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):209-14. PubMed ID: 3927536
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis.
    Foster CS; Alter G; DeBarge LR; Raizman MB; Crabb JL; Santos CI; Feiler LS; Friedlaender MH
    Am J Ophthalmol; 1996 Aug; 122(2):171-82. PubMed ID: 8694085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis.
    Sepah YJ; Sadiq MA; Chu DS; Dacey M; Gallemore R; Dayani P; Hanout M; Hassan M; Afridi R; Agarwal A; Halim MS; Do DV; Nguyen QD
    Am J Ophthalmol; 2017 Nov; 183():71-80. PubMed ID: 28887113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA).
    Nguyen QD; Merrill PT; Clark WL; Banker AS; Fardeau C; Franco P; LeHoang P; Ohno S; Rathinam SR; Thurau S; Abraham A; Wilson L; Yang Y; Shams N;
    Ophthalmology; 2016 Nov; 123(11):2413-2423. PubMed ID: 27692526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose cyclosporine treatment for sight-threatening uveitis: efficacy, toxicity, and tolerance.
    Mathews D; Mathews J; Jones NP
    Indian J Ophthalmol; 2010; 58(1):55-8. PubMed ID: 20029146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-masked controlled clinical trial of 5% tolmetin versus 0.5% prednisolone versus 0.9% saline in acute endogenous nongranulomatous anterior uveitis.
    Young BJ; Cunningham WF; Akingbehin T
    Br J Ophthalmol; 1982 Jun; 66(6):389-91. PubMed ID: 7044412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents.
    Walton RC; Nussenblatt RB; Whitcup SM
    Ophthalmology; 1998 Nov; 105(11):2028-34. PubMed ID: 9818601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of posterior uveitis with cyclosporin or prednisolone--one-year report of a randomized prospective study].
    Wiederholt M; Kämpe C; Hansen LL; Hövener G
    Fortschr Ophthalmol; 1986; 83(3):348-52. PubMed ID: 3527903
    [No Abstract]   [Full Text] [Related]  

  • 16. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis.
    Foster CS; Davanzo R; Flynn TE; McLeod K; Vogel R; Crockett RS
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):475-83. PubMed ID: 20809807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retina S antigen-induced uveitis. The efficacy of cyclosporine and corticosteroids in treatment.
    Striph G; Doft B; Rabin B; Johnson B
    Arch Ophthalmol; 1986 Jan; 104(1):114-7. PubMed ID: 3942532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine in the treatment of birdshot retinochoroidopathy.
    Le Hoang P; Girard B; Deray G; Le Minh H; De Kozak Y; Thillaye B; Faure JP; Rousselie F
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):128-30. PubMed ID: 3381267
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of endogenous uveitis with cyclosporine A.
    BenEzra D; Cohen E; Rakotomalala M; de Courten C; Harris W; Chajek T; Friedman G; Matamoros N
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):122-7. PubMed ID: 3381266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
    Nguyen QD; Merrill PT; Jaffe GJ; Dick AD; Kurup SK; Sheppard J; Schlaen A; Pavesio C; Cimino L; Van Calster J; Camez AA; Kwatra NV; Song AP; Kron M; Tari S; Brézin AP
    Lancet; 2016 Sep; 388(10050):1183-92. PubMed ID: 27542302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.